SCHEMBL9634543

SCHEMBL9634543

C#CCOc1ccc(C=O)c(OC)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.63
MAOB P27338 4/20 0.60
L3MBTL1 Q9Y468 1/20 0.47
CYP1A1 P04798 4/20 0.45
CYP1A2 P05177 4/20 0.45
CYP1B1 Q16678 4/20 0.45
TUBB1 Q9H4B7 1/20 0.45
KDM4E B2RXH2 2/20 0.44
TSHR P16473 2/20 0.44
GAA P10253 2/20 0.44
GLA P06280 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
GSTP1 P09211 1/20 0.43
MAOA P21397 1/20 0.42
TRIM24 O15164 1/20 0.41
TYR P14679 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
CA12 O43570 2/20 0.41
CA4 P22748 2/20 0.41
CA9 Q16790 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10733770 0.85 ALDH1A1 (0.63) ALDH1A1MAOBL3MBTL1CYP1A1CYP1A2
SCHEMBL19640030 0.84 MAOB (0.48) ALDH1A1MAOBL3MBTL1CYP1A2TUBB1
SCHEMBL702232 0.81 ALDH1A1 (0.71) ALDH1A1MAOBL3MBTL1CYP1A1CYP1A2
SCHEMBL31404213 0.80 CA12 (0.55) ALDH1A1MAOBKDM4ETSHRGAA
SCHEMBL1276085 0.80 CA12 (0.55) ALDH1A1MAOBKDM4ETSHRGAA
SCHEMBL1566049 0.80 ALDH1A1 (0.69) ALDH1A1MAOBL3MBTL1CYP1A1CYP1A2
SCHEMBL3905573 0.80 ALDH1A1 (0.69) ALDH1A1MAOBL3MBTL1CYP1A1CYP1A2
SCHEMBL14539352 0.80 ALDH1A1 (0.69) ALDH1A1MAOBL3MBTL1CYP1A1CYP1A2
SCHEMBL5654406 0.79 ALDH1A1 (0.63) ALDH1A1MAOBL3MBTL1CYP1A1CYP1A2
SCHEMBL96291 0.78 ALDH1A1 (1.00) ALDH1A1L3MBTL1CYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5104881-A 2-ARYLIMIDAZOPYRIDINES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1992-04-14 US disclosed
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 EP disclosed
US-4616090-A 2-arylimidazopyridines intermediates MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-10-07 US disclosed
EP-0072926-B1 2-ARYLIMIDAZOPYRIDINES MERCK PATENT GmbH (DE) 1986-09-24 EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 EP disclosed
EP-0072926-A1 2-Arylimidazopyridines MERCK PATENT GmbH (DE) 1983-03-02 EP disclosed